ValuEngine Lowers RECKITT BENCKIS/S (OTCMKTS:RBGLY) to Hold

Share on StockTwits

ValuEngine cut shares of RECKITT BENCKIS/S (OTCMKTS:RBGLY) from a buy rating to a hold rating in a report issued on Thursday, ValuEngine reports.

RBGLY has been the topic of a number of other research reports. Berenberg Bank initiated coverage on shares of RECKITT BENCKIS/S in a research note on Wednesday. They issued a buy rating on the stock. HSBC initiated coverage on shares of RECKITT BENCKIS/S in a research note on Friday, June 28th. They issued a buy rating on the stock. BNP Paribas reiterated a neutral rating on shares of RECKITT BENCKIS/S in a research note on Friday, July 5th. Zacks Investment Research upgraded shares of RECKITT BENCKIS/S from a sell rating to a hold rating in a research report on Tuesday, July 9th. Finally, Societe Generale lowered shares of RECKITT BENCKIS/S from a buy rating to a sell rating in a research report on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. RECKITT BENCKIS/S has a consensus rating of Hold and a consensus target price of $19.00.

RBGLY traded down $0.01 on Thursday, reaching $15.75. The company had a trading volume of 57,274 shares, compared to its average volume of 398,394. RECKITT BENCKIS/S has a fifty-two week low of $14.42 and a fifty-two week high of $18.85. The stock has a market cap of $55.84 billion, a P/E ratio of 17.50, a P/E/G ratio of 8.99 and a beta of 0.76. The company’s fifty day moving average is $15.82 and its 200 day moving average is $15.90.

About RECKITT BENCKIS/S

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Further Reading: What is the return on assets (ROA) ratio?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for RECKITT BENCKIS/S (OTCMKTS:RBGLY)

Receive News & Ratings for RECKITT BENCKIS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RECKITT BENCKIS/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Heico Corp  Receives $110.08 Average Target Price from Brokerages
Heico Corp Receives $110.08 Average Target Price from Brokerages
Polypipe Group  Stock Rating Lowered by Peel Hunt
Polypipe Group Stock Rating Lowered by Peel Hunt
Trevena Inc  Expected to Announce Earnings of -$0.08 Per Share
Trevena Inc Expected to Announce Earnings of -$0.08 Per Share
Trifast  Rating Reiterated by Peel Hunt
Trifast Rating Reiterated by Peel Hunt
Neumark Market Capitalization Reaches $3.66 Million
Neumark Market Capitalization Reaches $3.66 Million
Asura Coin  Trading Down 12.9% Over Last 7 Days
Asura Coin Trading Down 12.9% Over Last 7 Days


© 2006-2019 Ticker Report